Our in vitro results support the hypothesis that dysregulation of the miR-101/O-GlcNAcylation/EZH2 signaling regulatory feedback circuit promotes CRC metastasis; however, further investigations are required to fully verify this feedback circuit at the clinical level. The gene discussed is EZH2; the disease is colorectal carcinoma.